Fonterra Research Centre   Report issue

For profit Phase 3
Founded: Auckland New Zealand (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2009
NCT01171014
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Fonterra (Europe) Cooperatie U.A.

Active Ingredients

Drugs in Phase 3 Trials (1)

bifidobacterium lactis (3 trials)

Drugs in Other Trials (3)

anmum materna (1 trial)

bifidobacterium animalis (1 trial)

lactobacillus rhamnosus (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Constipation (Phase 3)

Influenza, Human (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4